Literature DB >> 27116023

A Model-Based Approach for Joint Analysis of Pain Intensity and Opioid Consumption in Postoperative Pain.

Rasmus V Juul1, Katrine R Knøsgaard1, Anne E Olesen1,2, Katja V Pedersen3,4, Mads Kreilgaard1, Lona L Christrup1, Palle J Osther3, Asbjørn M Drewes2, Trine M Lund5.   

Abstract

Joint analysis of pain intensity and opioid consumption is encouraged in trials of postoperative pain. However, previous approaches have not appropriately addressed the complexity of their interrelation in time. In this study, we applied a non-linear mixed effects model to simultaneously study pain intensity and opioid consumption in a 4-h postoperative period for 44 patients undergoing percutaneous kidney stone surgery. Analysis was based on 748 Numerical Rating Scale (NRS) scores of pain intensity and 51 observed morphine and oxycodone dosing events. A joint model was developed to describe the recurrent pattern of four key phases determining the development of pain intensity and opioid consumption in time; (A) Distribution of pain intensity scores which followed a truncated Poisson distribution with time-dependent mean score ranging from 0.93 to 2.45; (B) Probability of transition to threshold pain levels (NRS ≥ 3) which was strongly dependent on previous pain levels ranging from 2.8-15.2% after NRS of 0-2; (C) Probability of requesting opioid when allowed (NRS ≥ 3) which was strongly correlated with the number of previous doses, ranging from 89.8% for requesting the first dose to 26.1% after three previous doses; (D) Reduction in pain scores after opioid dosing which was significantly related to the pain intensity at time of opioid request (P < 0.001). This study highlights the importance of analyzing pain intensity and opioid consumption in an integrated manner. Non-linear mixed effects modeling proved a valuable tool for analysis of interventions that affect pain intensity, probability of rescue dosing or the effect of opioids in the postoperative pain period.

Entities:  

Keywords:  analgesic consumption; clinical data analysis; non-linear mixed effects modeling; pain intensity; postoperative pain

Mesh:

Substances:

Year:  2016        PMID: 27116023     DOI: 10.1208/s12248-016-9921-2

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  27 in total

Review 1.  Safety and efficacy of patient-controlled analgesia.

Authors:  P E Macintyre
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

2.  Overcoming obstacles to developing new analgesics.

Authors:  Clifford J Woolf
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

3.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 4.  Post-operative analgesic effects of paracetamol, NSAIDs, glucocorticoids, gabapentinoids and their combinations: a topical review.

Authors:  J B Dahl; R V Nielsen; J Wetterslev; L Nikolajsen; K Hamunen; V K Kontinen; M S Hansen; J J Kjer; O Mathiesen
Journal:  Acta Anaesthesiol Scand       Date:  2014-08-14       Impact factor: 2.105

5.  Pharmacodynamic modelling of placebo and buprenorphine effects on event-related potentials in experimental pain.

Authors:  Rasmus V Juul; David J R Foster; Richard N Upton; Trine Andresen; Carina Graversen; Asbjørn M Drewes; Lona L Christrup; Mads Kreilgaard
Journal:  Basic Clin Pharmacol Toxicol       Date:  2014-03-17       Impact factor: 4.080

6.  Assessment of pain intensity in clinical trials: individual ratings vs composite scores.

Authors:  Mark P Jensen; Catarina Tomé-Pires; Ester Solé; Mélanie Racine; Elena Castarlenas; Rocío de la Vega; Jordi Miró
Journal:  Pain Med       Date:  2014-10-03       Impact factor: 3.750

7.  Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia.

Authors:  M Silvasti; P Rosenberg; T Seppälä; N Svartling; M Pitkänen
Journal:  Acta Anaesthesiol Scand       Date:  1998-05       Impact factor: 2.105

8.  Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.

Authors:  Camilla Staahl; Richard Upton; David J R Foster; Lona Louring Christrup; Kim Kristensen; Steen Honoré Hansen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  J Clin Pharmacol       Date:  2008-05       Impact factor: 3.126

9.  A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.

Authors:  L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

10.  Decision tree-based learning to predict patient controlled analgesia consumption and readjustment.

Authors:  Yuh-Jyh Hu; Tien-Hsiung Ku; Rong-Hong Jan; Kuochen Wang; Yu-Chee Tseng; Shu-Fen Yang
Journal:  BMC Med Inform Decis Mak       Date:  2012-11-14       Impact factor: 2.796

View more
  4 in total

1.  Analysis of opioid consumption in clinical trials: a simulation based analysis of power of four approaches.

Authors:  Rasmus Vestergaard Juul; Joakim Nyberg; Mads Kreilgaard; Lona Louring Christrup; Ulrika S H Simonsson; Trine Meldgaard Lund
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-04-07       Impact factor: 2.745

2.  Quantification of the Pharmacodynamic Interaction of Morphine and Gabapentin Using a Response Surface Approach.

Authors:  Theodoros Papathanasiou; Rasmus Vestergaard Juul; Charlotte Gabel-Jensen; Mads Kreilgaard; Anne-Marie Heegaard; Trine Meldgaard Lund
Journal:  AAPS J       Date:  2017-08-29       Impact factor: 4.009

3.  Acute postoperative pain after arthroscopic rotator cuff surgery: A review of methods of pain assessment.

Authors:  Jacob Korsbæk Rasmussen; Lone Nikolajsen; Karen Toftdahl Bjørnholdt
Journal:  SICOT J       Date:  2018-11-22

Review 4.  Current Status and Future Directions of Pain-Related Outcome Measures for Post-Surgical Pain Trials.

Authors:  Ian Gilron; Henrik Kehlet; Esther Pogatzki-Zahn
Journal:  Can J Pain       Date:  2019-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.